Rigorous Evaluation of Primary and Secondary Overdose Prevention Activities Among Populations Disproportionately Affected by Overdose
ID: 353964Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$0 - $700K

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353964
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Rigorous Evaluation of Primary and Secondary Overdose Prevention Activities Among Populations Disproportionately Affected by Overdose." This funding opportunity aims to support research that evaluates prevention strategies aimed at reducing nonfatal and fatal overdoses, particularly among populations at higher risk due to social determinants of health. The initiative is crucial in addressing the ongoing public health crisis of drug overdoses, especially among youth and marginalized communities. The estimated total program funding is $4.9 million, with an award ceiling of $700,000 and an expected seven awards to be made. Interested applicants must submit their proposals electronically by December 2, 2024, and can direct inquiries to Candis M. Hunter at ncipc_erpo@cdc.gov.

    Point(s) of Contact
    ncipc_erpo@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    Drug-Free Communities (DFC) Support Program - NEW (Year 1)
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC), through the National Center for Injury Prevention and Control (NCIPC), is offering the Drug-Free Communities (DFC) Support Program grant for Fiscal Year 2025, aimed at supporting community coalitions in preventing and reducing youth substance use. This program seeks to establish and strengthen collaboration among various community sectors and organizations to address substance abuse, with a focus on developing partnerships and utilizing evidence-based strategies. The total estimated funding for this initiative is $62.5 million, with individual grants available up to $125,000 annually, and applications are due by May 5, 2025. Interested applicants can reach out to Christi Jones at dfcnofo@cdc.gov for further information.
    RFA-DD-18-000
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-DD-18-000, aimed at supporting health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with the program expected to award approximately 10 grants. This funding is crucial for enhancing public health efforts, although specific funding amounts have not been disclosed. Interested parties should submit their applications by October 13, 2025, and can direct inquiries to Linton C. Browning at lbrowning@cdc.gov or by phone at 770-488-2756.
    Occupational Safety and Health Education and Research Centers (T42)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is inviting grant applications for the Occupational Safety and Health Education and Research Centers (T42) program, aimed at enhancing occupational safety and health training. This initiative seeks to ensure a sufficient supply of qualified personnel to fulfill the mandates of the Occupational Safety and Health Act, with a focus on interdisciplinary training, research, and outreach in key disciplines such as industrial hygiene and occupational health nursing. With an estimated total program funding of $32 million, the CDC plans to award up to 18 grants, each ranging from $4.5 million to $9 million over a duration of 3 to 5 years. Interested applicants must submit their proposals electronically by October 26, 2028, and can direct inquiries to Dr. Elizabeth H. Maples at lbrowning@cdc.gov or by phone at 404-498-5014.
    Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity aimed at the development of medications to prevent and treat opioid and stimulant use disorders and overdose. This initiative seeks innovative preclinical and clinical research projects that can lead to FDA-approved therapies, focusing on areas such as prevention of substance use initiation, treatment adherence, and reduction of overdose risks. With a maximum funding amount of $3 million per year over a project period of five years, applicants are encouraged to submit proposals that demonstrate their capability to manage the research effectively, adhering to detailed application instructions. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for September 1, 2025.
    Advancing the Centers of Excellence in Newcomer Health
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Advancing the Centers of Excellence in Newcomer Health," aimed at enhancing health outcomes for immigrants and refugees in the United States. This cooperative agreement seeks innovative approaches to outreach and healthcare analysis for at-risk newcomer populations, focusing on areas such as health surveillance, clinical training, and the development of health orientation materials. With an estimated total program funding of $10 million and an award ceiling of $2 million, the CDC anticipates awarding two grants, with applications due by May 2, 2025. Interested applicants, specifically private institutions of higher education, can reach out to the Domestic Team at the Immigrant & Refugee Health Branch via email at IRHBdomestic@cdc.gov or by phone at 800-232-4636 for further information.
    RFA-CC-18-000
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-CC-18-000, aimed at supporting Type 6 Applications through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with no cost-sharing or matching requirements specified. This funding initiative is categorized under health-related activities, with an expected total of 100 awards available, although the award ceiling and floor are both set at zero. Interested parties should note that the application deadline is October 13, 2025, and may contact Linton C. Browning at lbrowning@cdc.gov or by phone at 770-488-2756 for further information.
    RFA-DP-18-000
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-DP-18-000, aimed at supporting various health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with the program designed to facilitate Type 6 Applications as necessary. This funding opportunity is significant for enhancing public health efforts, with an expected total of 100 awards available, although no specific funding amounts are indicated. Interested parties should note that the application deadline is October 13, 2025, and can reach out to Linton C Browning at lbrowning@cdc.gov or by phone at 770-488-2756 for further information.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative, structured as a cooperative agreement, focuses on three key components: enhancing healthcare provider knowledge and practices regarding Chagas disease, expanding public health surveillance for soil-transmitted helminths, and addressing other significant parasitic diseases of domestic concern. With an estimated total program funding of $10 million and an award ceiling of $1 million, the CDC anticipates making approximately seven awards, with applications due by May 2, 2025. Interested applicants can reach out to Emily Dodd at 404-639-3753 or via email at iog2@cdc.gov for further information.
    RFA-OE-18-000
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-OE-18-000, aimed at supporting various health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with the program designed to facilitate Type 6 Applications as necessary. This funding opportunity is significant for enhancing public health efforts, with an expected total of 100 awards available, although no specific funding amounts have been established. Interested parties should note that applications are due by October 13, 2025, and can direct inquiries to Linton C Browning at lbrowning@cdc.gov or by phone at 770-488-2756.
    Drug-Free Communities (DFC) Support Program - Competing Continuation (Year 6)
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC), through its National Center for Injury Prevention and Control (NCIPC), is offering the Drug-Free Communities (DFC) Support Program - Competing Continuation (Year 6) grant opportunity aimed at reducing substance use among youth. This program is designed for community-based coalitions that have previously received DFC grants and are either concluding their initial five-year funding cycle or have experienced a lapse in funding, with the goal of fostering collaboration to prevent and reduce youth substance use. The total funding available for this initiative is $31.25 million, with approximately 100 grants expected to be awarded, each averaging $125,000 over a five-year period. Interested applicants must submit their proposals electronically by May 5, 2025, and can direct inquiries to Christi Jones at dfcnofo@cdc.gov.